| __timestamp | BioCryst Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 242549000 |
| Thursday, January 1, 2015 | 72758000 | 245098000 |
| Friday, January 1, 2016 | 61008000 | 147600000 |
| Sunday, January 1, 2017 | 66962000 | 264600000 |
| Monday, January 1, 2018 | 84888000 | 357900000 |
| Tuesday, January 1, 2019 | 107068000 | 1182600000 |
| Wednesday, January 1, 2020 | 122964000 | 357700000 |
| Friday, January 1, 2021 | 208808000 | 540100000 |
| Saturday, January 1, 2022 | 253297000 | 322900000 |
| Sunday, January 1, 2023 | 216566000 | 408000000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
United Therapeutics has consistently outpaced BioCryst, with R&D expenses peaking in 2019 at nearly four times that of BioCryst. This trend highlights United Therapeutics' aggressive pursuit of new therapies, particularly in the field of pulmonary arterial hypertension. Meanwhile, BioCryst has shown a steady increase in R&D spending, culminating in a 2022 peak that was nearly five times its 2014 level. This growth underscores BioCryst's focus on rare disease treatments.
As the biotech landscape evolves, these spending patterns offer a glimpse into the strategic priorities of these two industry players, reflecting their commitment to advancing medical science.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.